drugset
drugset / Trial / NCT03749408

Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain

NCT03749408 ↗

Phase 2/3 Completed 60 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

Inferior alveolar nerve block using either 0.5% bupivacaine alone or in addittion to mannitol in patients with irreversible pulpitis in mandibular molars.

Timeline

Start
2012-12
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Comparator Mannitol Diagnostic / imaging agent 1.5 ml Other

Indications

pulpitis